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Proline is exceptional in the sphere of amino acids in its ability to
adopt cis and trans conformations, which allows a protein backbone
switch that is controlled by prolyl cis/trans isomerization [1]. Many of
the biological events that occur under strict time control, such as the
eukaryotic cell cycle and cell proliferation, are affected by the catalytic
action of peptidyl-prolyl cis/trans isomerases (PPIases, EC 5.2.1.8)
(Reviewed in [2]). PPIases are ubiquitous enzymes that can abolish
slow kinetic phases in protein folding by accelerating cis/trans
isomerization of peptide bonds preceding a proline residue within a
polypeptide chain. Based on inhibitor susceptibility and sequence
homology, PPIases have been divided into three distinct classes: the
cyclosporin A (CsA)-binding proteins (cyclophilins), the FK506-
binding proteins (FKBPs) and the parvulins, which do not bind any
immunosuppressant drugs [3].A key breakthrough in appreciating the signiﬁcance of conforma-
tional changes was the discovery of the parvulin-type PPIase Pin1 [4].
This parvulin is a prolyl isomerase that speciﬁcally isomerizes the
phosphorylated Ser/Thr-Pro bonds regulating the function of mitotic
phosphoproteins [5–7]. Pin1 binds proteins that have been phos-
phorylated by Pro-directed kinases such as cyclin-dependent kinases
(CDK) and mitogen-activated protein kinases (MAPK), and induces a
conformational change to regulate their function by triggering a
programmed set of cell cycle events [4,8].
On the basis of substrate speciﬁcity, the eukaryotic parvulin family
can be subdivided into two groups: proteins that clearly accelerate cis/
trans isomerization of phosphor-(Ser/Thr)-Promoieties, as it has been
demonstrated for human Pin1 (hPin1) [4], yeast Ess1 [9] and some
Pin1-type plant parvulins [10–12], and proteins that do not show any
preference for phosphorylated substrates, such as hPar14 [13]. Human
Pin1, like other Pin1-type PPIases, contains two domains that are
important for the in vivo function of these proteins: anN-terminalWW
domain and a C-terminal PPIase domain. The WW domain consists of
35- to 40-amino acid residues and acts as a protein–protein interaction
module in many different proteins [14]. Depletion of hPin1 in HeLa
cells and depletion of its functional homolog Ess1 in yeast results in
mitotic arrest, while overexpression causes G2 arrest [4]. Pin1 is
mainly localized in the nucleus [4,15] and interacts speciﬁcally with
proteins involved in cell cycle regulation [7]. In addition, Ess1 and Pin1
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RNA polymerase II (Pol II) and other proteins that are important for
RNA-Pol II transcription and regulation [16–19].
On the other hand, human Par14 lacks the N-terminal WW domain
of hPin1 and carries an unstructured N-terminal extension which is
indispensable for its nuclear localization and binding to DNA [20,21].
Although hPar14 cannot rescue the lethal phenotype of Ess1 deletion,
which is the only parvulin-type PPIase in yeast [11], Uchida and co-
workers [22] proposed a compensating function for hPar14 upon hPin1
inhibition or deletion in mammalian cells. In addition, hPar14 has been
proposed as an hPin1 complementing enzyme in cell cycle regulation
and chromatin remodeling [21,22]. This parvulin displays a strong
preference for peptide substrates containing an Arg side-chain preced-
ing the Pro residue but not for phosphorylated Ser/Thr, as is the case of
Pin1, and hence might also perform cellular regulatory functions
different from those of Pin1 [13]. Recently, it has been reported that
Par14 associates with multiple pre-ribosomal ribonucleoprotein (pre-
rRNP) complexes formed at the various stages of mammalian ribosome
biogenesis and that its knockdown suppresses cell growth [23].
The TriTryp kinetoplastids Trypanosoma cruzi, Trypanosoma brucei
and Leishmania major are causative agents of different human
diseases: Chagas' disease, sleeping sickness and leishmaniasis,
respectively. We have previously reported the characterization of a
Pin1-like PPIase named TcPin1 from T. cruzi [24]. Like all plant Pin1-
like enzymes characterized so far, TcPin1 lacks the WW module.
Additionally, in contrast to that observed with hPin1-related proteins,
TcPin1 is not nuclear. Aided by the availability of the completed
genome sequence of T. cruzi, we have now identiﬁed a newmember of
the parvulin family of PPIases named TcPar45, which is conserved in
the TriTryp genome. Interestingly, a WW domain is not apparent in
TcPar45, but the presence of a forkhead-associated (FHA) domain in
its place indicates that it may serve an equivalent function. To our
knowledge, TcPar45 is the ﬁrst example of a FHA domain present in
the same polypeptide with a PPIase domain.
To elucidate a possible role for TcPar45we studiedherein its possible
activity as a PPIase enzyme, its cellular localization and its substrate
preferences. Additionally, we present an entire comparison of the
substrate preference of all three parvulin-type PPIases, TcPin1, TcPar14
and the novel TcPar45. We found that TcPar45 acts preferentially on
substrates containing the basic Arg residue preceding Pro and does not
complement yeast Ess1 temperature-sensitive mutants. These results
are unexpected since the amino acid sequence of the catalytic coreof the
enzymeshows a high degree of similarity to Pin1-like PPIases,which are
phosphorylation-dependent. Knockdown of the homologous protein in
T. brucei (TbPar45) by RNA interference (RNAi) caused a slow-growth
phenotype, with amarginal increase in anomalous cells, thus indicating
that it is required for normal cell proliferation.
This study provides new insights into the importance of a
phosphorylation-independent parvulin-type PPIases.
2. Materials and methods
2.1. Sequence and phylogenetic analyses
Multiple protein alignments were based on the ClustalW algo-
rithm using the NTI Vector Suite software (Informax Inc. Bethesda,
MD, USA). A phylogenetic tree was built using the online service
phylogeny.fr [25] (“A la carte” Mode), which implements the
distance-based method Neighbor [26] for the construction of the
phylogenetic tree and Treedyn to produce the image presented here.
2.2. Cell cultures
T. cruzi epimastigote, bloodstream trypomastigote and intracellu-
lar amastigote cells from the CL-Brener strain were cultured as
previously described [24].2.3. Cloning of TcPar14 and TcPar45 PPIases and their expression in
Escherichia coli
The coding regions of the parvulins were ampliﬁed from genomic
DNA by PCR using Pfu polymerase. PCR reaction conditions were as
follows: initial denaturationcycle at 94 °C for 1 min, followedby25cycles
of 94 °C for 1 min, 60 °C for 20 s, 72 °C for 1–2 min, and a ﬁnal extension
of 10 min at 72 °C. The primers for PCR cloning of the TcPar14 gene were
Par14F 5′-AAGGATCCGATGGGCAAGG AGAAGAA-3′ and Par14R 5′-
ATCCTCGAGCTG TTTGTCCTCA ACCAA-3′ as sense and antisense primers
respectively. The inserted restriction sites are underlined. The primers for
PCR cloning of the region encoding the C-terminal end of the TcPar45
gene were Par45F 5′-TTGGATCCAACCATCAACGCGAG G-3′ and Par45R
5′-ATAGTCGACCTACTCCGCGCGGTAAA-3′ as sense and antisense pri-
mers, respectively. ThePCRproduct corresponding to the full-lengthgene
sequence of TcPar14was inserted into the pET22b(+) (Novagen) vector
by constructing unique BamHI and XhoI sites at the 5′ and 3′ ends of the
coding regions. The 546-bp band corresponding to the gene sequence
encoding the C-terminal end of TcPar45 (residues 241–421) was cloned
into the BamHI and SalI restriction sites of the pET28a expression vector
to generate the recombinant protein with an N-terminal histidine tag.
The cloned PCR fragmentswere sequenced using single primer extension
to conﬁrm that no PCR-induced mutations had been introduced
(Macrogen Inc.).
2.4. Recombinant protein expression
For expression of recombinant pET22/TcPar14-His6 and pET28/
His6-TcPar45PPIase (residues 241–421), the E. coli strain BL21-
CodonPlus (DE3)-RIL was used. Cells were grown at 37 °C in LB
medium to an A600 nm of 0.7. Protein expression was induced by
adding IPTG, to a ﬁnal concentration of 0.5 mM and incubating for 5 h.
Subsequently, the bacterial pellet from a 6×1 L culture was harvested
and resuspended in lysis buffer containing 25 mM Tris/HCl buffer, pH
8.0, 300 mM NaCl, 5% glycerol, 5 mM MgCl2, 10 mM imidazole and
protease inhibitor cocktail (Roche), and lysed on a SLM Aminco
French pressure cell. The extract was then clariﬁed by ultracentrifu-
gation at 50,000×g for 30 min and the supernatant was loaded on a
nickel-nitrilotriacetic acid-agarose afﬁnity resin previously equili-
brated with the same buffer at 4 °C. Elution was carried out in a 50- to
300-mM imidazole gradient and fractions containing the enzymes
were pooled and protein purity was analyzed on 15% (w/v) SDS-PAGE
stained with Coomassie blue. Proteins were dialyzed against 10 mM
HEPES pH 7.8, 1.5 mM MgCl2, 150 mM KCl and 1.0 mM DTT and
concentrated by using Centricon (Millipore) tubes. Finally, samples
were applied to a Superdex 75 column (Amersham Pharmacia)
equilibrated in the same buffer. Fractions were collected, analyzed by
SDS-PAGE and the resulting fractions containing the enzymes were
used for determinations of PPIase activity.
2.5. Antibody generation and puriﬁcation
Antibodies to TcPar14 and TcPar45 were generated in rabbit with
His-TcPar14 and His-TcPar45PPIase fusion proteins as antigens, respec-
tively. The immunization followed a standard protocol. For afﬁnity
puriﬁcation, His-TcPar14 and His-TcPar45PPIase fusion proteins were
independently coupled to Afﬁ-Gel 10 (Bio-Rad) according to the
manufacturer's protocol. Complete serum was incubated with the
column at 4 °C and speciﬁc antibodies were eluted using 0.1 M glycine
pH 2.5. Samples were neutralized and protein concentration was
assayed. The antibody to TcPin1 has been previously described [24].
2.6. PPIase: peptidyl-prolyl cis/trans isomerase activity assay
PPIase activity was assayed basically as previously described [24],
using the protease-free PPIase assay according to Janowski et al. [27].
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buffer, pH 7.8, with a Hewlett-Packard 8453A UV/Vis spectropho-
tometer. A 30-mM stock solution of the substrates (Bachem) in 0.5 M
LiCl/TFE (2,2,2-Triﬂuoroethanol anhydrous) was freshly prepared
before the measurements. Prior to every measurement, all compo-
nents except the substrate were preincubated for 300 s at 10 °C under
vigorous stirring. Each measurement was started after substrate
addition (60 μM ﬁnal substrate concentration) and the cis/trans
isomerization kinetics of the substrate was followed at 330 nm.
2.7. Yeast complementation analysis
The yeast complementation assay was performed as previously
described [24]. Brieﬂy, the T. cruzi parvulins TcPin1, TcPin1R20A,
TcPar14 and TcPar45 full-length were subcloned into the yeast
expression vector pJK305-TPI, which allows constitutive expression
of the protein. Temperature-sensitive yeast cells (MATa ess1H164R
integrated into the W303 1A yeast strain) [28] were grown overnight
in YPAD (yeast extract/peptone/adenine/dextrose) medium at 30 °C
and were then transformed with the different constructions via
electroporation. Gene expression in the stably transformed YGD-
ts22W strains was controlled by Western blot analysis of the cell
lysates from cultures grown at permissive temperature (30 °C) using
the speciﬁc antibodies. For the complementation analysis, cells of the
respective strain selected in the appropriate medium at permissive
temperature were resuspended in 10 mM Tris/HCl buffer, pH 7.5,
1 mM EDTA and the optical density adjusted to A600=0.5. A 10-fold
series dilution was performed and 5 μl of each dilution was spotted
onto the plates. In order to test for functional complementation, the
cells were incubated at both permissive (30 °C) and non-permissive
(37 °C) temperatures. Cells carrying both the pJK305-TPI vector
without the insert and human Pin1 were used as controls.
2.8. Immunoﬂuorescence microscopy
T. cruzi epimastigote and T. brucei procyclic cells were washed with
PBS, attached to 0.1% poly-L-lysine-coated glass slides and ﬁxed with
4% formaldehyde in PBS for 20 min, and then permeabilized with 0.1%
Triton X-100 in PBS for 5 min at room temperature. Par45 was
detected by incubating cells with the rabbit afﬁnity-puriﬁed antibody
diluted to 1:400 in PBS. The Alexa Fluor 546-conjugated goat anti-
rabbit antibody (Molecular Probes, 1:500) was used as the secondary
antibody. The ﬂagellum was revealed by anti-paraﬂagellar rod (anti-
PFR) monoclonal antibody (1:2; hybridoma supernatant provided by
Dr. S. Schenkman), followed by an Alexa Fluor 488-conjugated anti-
mouse secondary antibody (Molecular Probes, 1:500). V5-tagged
Par45was detectedwith themousemonoclonal antibody (Invitrogen;
1:200) and the Alexa Fluor 546-conjugated goat anti-mouse antibody
(Molecular Probes, 1:500). Nuclear and mitochondrial DNA was
stained with DAPI. All slides were mounted in Vectashield (Vector) in
the presence of 10 μg of DAPI per ml. Serial images (0.2-μm Z-
increment) were collected using a 100× objective 1.35 NA using the
Cell M software in a motorized Olympus IX81 microscope. Images
were processed by blind deconvolution using Autoquant X 2.1.
Alternatively, images were taken using an Olympus BX41 light and
ﬂuorescence microscope with an Olympus DP71 digital camera and
capture software (Olympus America, Inc, Center Valley, PA) and
exported as TIFF ﬁles for assembly in Adobe Photoshop CS3 (Adobe
System, Inc., San Jose, CA).
2.9. Parasite transfection and RNAi experiments
For transfection of theprocyclic T. brucei form, 107 cellswerewashed
once in 5 ml of cytomix [29] and resuspended in 0.5 ml of cytomix
containing 10 μg of NotI linearized plasmid so that it could target the
rDNA spacer region [30]. Transfections were carried out in 4-mmcuvettes using a Bio-Rad electroporator with peak discharge at 1.6 kV
and 25 μF of capacitance. Immediately after transfection, cells were
transferred into 10 ml of SDM-79 supplemented with G418 and
hygromycin. After 1 day, selection was applied by culturing the cells
in thepresence of 2.5 μg/mlphleomycin for 2 weeks to formstable lines.
RNAi experiments used the procyclic T. brucei 29-13 strain which
harbors genes for T7 RNA polymerase and the tetracycline repressor
[31]. Procyclic parasites were cultured at 28 °C in SDM-79 medium
containing 10% fetal bovine serum (FBS, PAA Laboratories GmbH).
Media were supplemented with appropriate selection agents (hygro-
mycin, 50 μg/ml; G418, 15 μg/ml; phleomycin, 2.5 μg/ml; blasticidin,
10 μg/ml). For RNAi, T. brucei 29-13 expressing V5-tagged Par45 was
transfectedwith thepZJMvector [30],whose insertwas a PCR-ampliﬁed
fragment of the TbPar45 gene (encoding amino acid residues 21–189;
accession number Q57XM6). After drug selection, the transfected cells
were cloned by limiting dilution, generating independent Par45RNAi
cell lines. To evaluate the effects of RNAi on cell proliferation, cells
cultured in SDM-79 in the absence (−tet) or presence (+tet) of
tetracycline were counted daily and cumulative growth curves for each
clonewereplottedona logarithmic scale. In situ tagged TbPar45ORFwas
obtained by amplifying ∼300 bp regions in the 5′UTR of the gene and
the 5′ region of the ORF. The primers UTRPar45F 5′-TACCGCGG
CATTTTCGATGCAC-3′ and UTRPar45R 5′-CCTCTAGATTCCTC-
CACCCCTCGC-3′ were used to amplify the 5′UTR region, whereas the
primers ORFPar45F 5′-CGCTCGAGATGGTTA CCTCTACTGC-3′ and ORF-
Par45R 5′-ATGGGCCCGTCGCCTCTT CT-3′ were used to amplify the 5′
region of the ORF. The fragments were cloned both upstream and
downstream of the BLA/V5 cassette [32] to yield the plasmid pBLA/V5-
Par45. This plasmid was digested with ApaI/NotI and transfected into
procyclic 29-13 T. brucei. For detection of V5-tagged proteins, a 1/1000
dilution of the anti-V5 antibody (Invitrogen) was used.
2.10. Northern blot
Total RNAwasobtainedusing TRIzol reagent (Invitrogen) according
to the manufacturer's instructions and Northern blotted as previously
described [24]. Probes for TbPin1 (AAX69357), TbPar14 (Tb927.3.3100)
and TbPar45 (Q57XM6) were full-length open reading frames. The
probes were radiolabeled with [α-32P] dCTP (109 cpm pmol−1, NEN)
using the Prime-a-Gene Labeling System (Promega). Quantiﬁcation
was performed using a phosphorimager Storm 820 (Amersham
Pharmacia Biotech) and ImageQuant software. Ribosomal RNA was
used to measure loading. Experiments were performed at least twice
and representative results from individual experiments are shown.
2.11. Other procedures
A Western blot was performed as described previously [24]. The
mousemonoclonal anti-β tubulin was purchased from Amersham Life
Science. Epimastigote cells from the Tulahuen strain were synchro-
nized as described previously [33]. Samples were analyzed using a
Becton Dickinson ExCalibur Flow Cytometer (Becton Dickinson, San
Jose, CA) and graphed using WinMid 2.9 software.
3. Results
3.1. TcPar45 is a new member of the parvulin family of PPIases in
trypanosomes
Two eukaryotic parvulin-related PPIases, hPin1 [4] and hPar14 [13],
havebeenpreviously identiﬁed inhumans.Wehavepreviously reported
two parvulins in T. cruzi, named TcPin1 and TcPar14, as molecular
homologs of the human Pin1 and Par14 PPIases, respectively [24]. We
used humanparvulin protein sequences to search for additional putative
PPIases in the genome of T. cruzi. Both queries gave high amino acid
identity scores over the parvulin catalytic domain (35.4% and 17.7%
1031E.D. Erben et al. / Biochimica et Biophysica Acta 1803 (2010) 1028–1037respectively) for aprotein encodedby agene annotatedas ahypothetical
protein in GeneDB (http://www.genedb.org/) data base (Tc00.10470
53509207.130). We have named this protein TcPar45 (for T. cruzi
Parvulin) according to Fischer [34]. TcPar45 encodes a 421-amino-acid
protein, which has a predicted size of 45.4 kDa. It encodes a parvulin
domain highly similar to that of Pin1-like PPIases and anN-terminal FHA
domain usually found in proteins involved in nuclear signaling [35]. AnFig. 1. Multiple sequence alignment of Par45-related proteins (Panel A). Identical (black
highlighted. The residues shown by both the crystal structure of human Pin1 [5] and site-dire
are indicated by triangles. The residues believed to be important for PPIase activity are highlig
The sequences were aligned over their entire length using ClustalW. Phylogenetic tree for th
method Neighbor [26] (1000 bootstrap replicates) based on amultiple sequence alignment g
colors correspond to different parvulin subfamilies: phosphorylation-dependent PPIases (red
substrate speciﬁcity (green) [13,52]. Sequences included are as follows: TcPar45 is from T. c
(CAA59961) [50], hPin1 and hPar14 from humans (AAC50492 and AB009690, respectively)
(AJ133755) [11],MdPin1 fromMalus domestica [12], TbPin1 and TbPar14 from T. brucei (AAX6
DQ420359, respectively) [24], LmPin1 and LmPar45 from L. major (CAJ07069 and LmjF22.0alignment of the PPIase domain of the Par45 sequencewith homologs of
hPin1 from selected organisms is shown in Fig. 1, panel A. A search in the
TriTryp genome databases revealed that putative Par45-type PPIases
homologs are present in all trypanosomatids, with a high degree of
identity. The TcPar45 catalytic domain (residues 309–421) shares a high
degree of homology with the phosphorylation-dependent eukaryotic
Pin1-type. The degree of homology to the PPIase domains of other Pin1-) or conservatively substituted (gray) residues in at least 50% of the sequences are
cted mutagenesis experiments [5,36,37] to be within the active site of the PPIase moiety
hted in black triangles when conserved between TcPar45 and hPin1; otherwise in gray.
e parvulin proteins (Panel B). The phylogenetic tree was built using the distance-based
enerated using ClustalW. The tree is drawn to scale using Treedyn. Different background
) [10–12,24,50,51], Par45-related (blue, this work), and a group of proteins with varying
ruzi (FJ409872), TbPar45 from T. brucei (Q57XM6), Ess1 from Saccharomyces cerevisiae
[13,51], AtPin1 from Arabidopsis thaliana (AAD20122) [10], DlPin1 from Digitalis lanata
9357 and Tb927.3.3100, respectively), TcPin1 and TcPar14 from T. cruzi (DQ303420 and
530, respectively) and EcPar10 from E. coli (S48658) [52].
Fig. 2. (A)Western blot analysis of TcPar45. Immunoblot analysis of whole-cell extracts
from epimastigote (E), amastigote (A) and trypomastigote (T) form cells (60 μg each)
and the recombinant His-tagged TcPar45PPIase protein puriﬁed from E. coli (200 ng) as
control, resolved by SDS-PAGE (10% gels), electrotransferred onto Hybond C
membranes, and revealed with afﬁnity-puriﬁed anti-TcPar45 antibody (1:1000; left).
The position of 45 kDa TcPar45 is indicated. Pre-immune (PI) serumwas used as control
(1:1000; right). (B) TcPar45 levels are constant during the cell cycle. Epimastigote cells
were harvested at the indicated times after HU removal and aliquots were subjected to
ﬂow cytometric analysis to determine the cell cycle status and the remaining cells were
analyzed for protein expression by immunoblotting. (left) Flow cytometric analysis of
the DNA content. Cells at 0 (G1), 6 (S), 14 (G2/M) and 18 hours after release from HU
are shown. (right) The same amounts of total proteins (60 μg) were separated on an
SDS-containing gel, transferred to a membrane and probed with anti-TcPar45 (1:1000;
upper) and anti-β tubulin antibodies (1:5000; bottom).
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cerevisiae, 33%withAtPin1 and27%with TcPin1 from T. cruzi. There is less
sequence homology with other parvulins with a rather unspeciﬁc
substrate recognition pattern, such as EcPar10 from E. coli, which has
19% identity to the PPIase domain of TcPar45.
Residues essential for catalysis have been proposed for Pin1-like
parvulins based on a complex structure of human Pin1 with an Ala-
Pro dipeptide and a sulphate bound to the active site [5] in line with
site-directed mutagenesis experiments [5,36,37]. The phosphate
binding site, which is deﬁned by Lys63, Arg68, and Arg69 and thought
to be the catalytic loop in hPin1, is conserved among the Pin1-type
parvulins and the novel TcPar45 (Fig. 1, panel A). In the TcPar45
enzyme, the speciﬁc sequence features exist as Lys312, Arg317, and
Arg318. Remarkably, the PPIase protein sequence of TcPar45 is closer
to that of human Pin1 [5,36,37] and shows a better conservation of
critical residues than that of hPar14 [38,39] (Fig. 1, panel A). The
phylogenetic relationship between the 15 parvulin sequences used in
the multiple alignment is shown in Fig. 1, panel B. This phylogeny,
based on the PPIase domain sequences of parvulins, supports the
existence of a novel parvulin family with unique features.
Proteins sharing similar domain architecture are present only in a
few other eukaryotic organisms. A search in all publicly available
genome databases revealed that putative Par45 orthologs are present
in the slime mold Dictyostelium discoideum and in the unicellular
green alga Chlamydomonas reinhardtii. In addition to protozoa and
algae, we detected several divergent proteins containing the single
module protein–protein interaction FHA domain, showing similarity
to that of Par45. The protein–protein interaction domain of TcPar45
showed 38% amino acid sequence identity to the FHA domain of NIPP1
(nuclear inhibitor of protein phosphatase 1). However, this divergent
protein does not contain a PPIase domain.
These characteristics indicate that TcPar45 is an atypical member
of the parvulin family, distinct from those previously characterized in
mammals, yeast and plants.
3.2. Detection of the native protein in parasite extracts
The expression pattern of T. cruzi Par45 protein was studied in all
life cycle stages of the parasite using serum afﬁnity-puriﬁed
antibodies obtained against the recombinant TcPar45PPIase protein.
As shown in Fig. 2A, the anti-TcPar45 antiserum recognizes a 45-kDa
protein in total cell extracts in all three life cycle stages of the parasite.
On the other hand, the pre-immune serum did not react with parasite
protein lysates. Next, we asked whether Par45 protein levels
ﬂuctuated during the cell cycle. To address this question, epimastigote
cells were hydroxyurea (HU) synchronized [33]. After removal of the
HU, the cells underwent a short lag period and then proceeded
synchronously through the cell cycle. At different times after the
release from the block, cells were harvested and analyzed by ﬂow
cytometry or lysed and analyzed for protein expression by immuno-
blotting. Analysis of the DNA content indicated that the cells
progressed synchronously through different phases of the cell cycle
(Fig. 2B, left). Nonetheless, total Par45 levels did not change
signiﬁcantly during the cell cycle (Fig. 2B, right).
3.3. TcPar45 is a functional PPIase in vitro
Attempts to produce Par45 as a full-length recombinant protein in
E. coli were unsuccessful. The overexpression of Par45 inhibited the
bacterial growth rapidly after inducing parvulin expression. This
phenomenon was most likely caused by its FHA domain, given that
the overexpression of this isolated domain causes the same
phenotype (data not shown). Therefore, the function of TcPar45 as a
PPIase was tested by expressing a C-terminal fragment containing the
catalytic domain of the enzyme. For identiﬁcation, themolecular mass
of 6xHis-TcPar45PPIase was determined at 22,937 Da by matrix-assisted laser desorption time-of-ﬂight mass spectrometry (data not
shown). The PPIase activity of the puriﬁed C-terminal fragment of
TcPar45 was determined by using the protease-free assay. Under
these conditions, the substrate speciﬁcity of the isolated catalytic
domain of TcPar45 toward the substrate succinyl-Ala-Arg-Pro-Phe-
NH-Np resulted in a kcat/KM value of 97.1 (±1.7)×103 /M/s, whereas
the isomerase activity for substrates containing different Pro bonds
exhibited lower activity (Table 1). The relative speciﬁcity values for
various substrates showed a pattern similar to that of the human and
trypanosome Par14, with a preference for a substrate with the basic
Arg residue preceding proline. For instance, the substrate Suc-Ala-
Arg-Pro-Phe-NH-Np was interconverted with a speciﬁcity constant
kcat/KM of 194 /mM/s by TcPar14. This is about 50-fold higher than
the respective value of kcat/KM for human Par14 [13].
In contrast to Pin1-like PPIases, but similarly to TcPar14,
TcPar45PPIase does not accelerate the cis to trans interconversion of
substrates with negatively charged Glu amino acid residues preceding
Pro bonds (Table 1), despite the high sequence identity of the PPIase
active sites (Fig. 1, panel A). These results indicate that TcPar45 is
active as a PPIase enzyme and suggest that this parvulin is more
speciﬁc towards substrates containing a basic Arg residue preceding
proline.
3.4. Yeast complementation analysis
We have previously demonstrated that TcPin1, similarly to Pin1-
like PPIases, is able to complement the otherwise lethal Ess1 loss in S.
cerevisiae [11,12,24]. Given the homology of the PPIase catalytic
domains of TcPar45, TcPin1 and human Pin1 we decided to evaluate
whether Par45 is able to replace Pin1/Ess1 functions in yeast. The
strain used grows normally at 30 °C but arrests at G2/M transition
after two to three generations at 37 °C (restrictive temperature) [28].
The complete parvulin genes of T. cruzi were subcloned in the S.
Table 1
Substrate speciﬁcity constants (kcat/KM) of TcPar45PPIase and comparison of the
speciﬁcity pattern to related T. cruzi PPIases.
Xaa TcPar45PPIase TcPar14 TcPin1
kcat/KM
(×103 /M/s)
Relative activity
(%)
Relative activity
(%)
Relative activity
(%)
Arg 97.1 (± 1.7) 100 100 100
Glu 7.4 (± 0.8) 7.6 0.9 3202
Phe 4.2 (± 0.1) 4.3 0.6 26.6
Leu 25.9 (± 2.1) 26.7 2.4 141.1
Ala 6.7 (± 0.3) 6.9 1.0 124.2
Substrates were of the type Suc-Ala-Xaa-Pro-Phe-NH-Np, where Xaa stands for a
variable amino acyl residue. The relative activities were normalized to the value of kcat/
KM of the substrate Suc-Ala-Arg-Pro-Phe-NH-Np. The values for that substrate were
estimated as follows: T. cruzi Par14 kcat/KM=194 /mM/s and TcPin1 kcat/KM=12.4 /
mM/s. The values concerning TcPin1 were calculated from data of [24] and from this
work. PPlase measurements were performed in a protease-free assay as described
under Materials and methods.
Fig. 3. Only TcPin1 can suppress the temperature-sensitive phenotype of the yeast
strain YGD-ts22W under non-permissive temperature. (A) The strain was transformed
with the yeast expression vector pJK305-TPI containing the coding sequence of the T.
cruzi parvulins TcPin1, TcPin1R20A, TcPar14 and TcPar45. Data were obtained after 2–
4 days of incubation at permissive (30 °C) or non-permissive temperatures (37 °C).
From left to right, 10-fold dilutions of the initial cell suspension were plated into
synthetic selective media (without leucine). Cells expressing either hPin1 (upper) or
the empty vector (bottom) were used as positive and negative controls respectively. (B)
Similar expression of transgenes in yeast cells. YGD-ts22W strains stably transformed
with various T. cruzi parvulin constructs were subjected to immunoblotting analysis
using speciﬁc afﬁnity-puriﬁed antibodies (1:500 dilutions) obtained as described under
Materials and methods. Cells transfected with the empty vector were separated by
electrophoresis and revealed using anti-TcPar45 antibody (1:500 dilution).
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budding yeast Ess1ts. As it has been previously described [24], after
selection on Leu-deﬁcient minimal medium plates, only colonies
containing the TcPin1 gene grew at the restrictive temperature
(Fig. 3A). In contrast, neither TcPar14 nor TcPar45 abolished the
temperature sensitivity of the yeast cells. Moreover, a point-mutation
variant of TcPin1 (TcPin1Arg20Ala), engineered to make the coordina-
tion of the phosphate group of the substrate impossible, was not able
to rescue the lethal phenotype (Fig. 3A). In the same set of
experiments, human Pin1 was used as a positive control. Immuno-
blotting analysis of lysates from YGD-ts22W cells transformed with
the different constructs using speciﬁc antibodies showed that all
proteins were expressed at comparable levels (Fig. 3B). Intriguingly,
we observed that TcPar45 displays an apparently higher molecular
weight than the expected one, probably due to post-translational
modiﬁcations occurring in the yeast. Failures of transformed mutant
cells to grow at 37 °C are in agreement with the kinetics parameters
observed in the in vitro PPIase assay.
3.5. TcPar45 is a nuclear protein
A large number of the characterized FHA-containing proteins have
been reported tobe localized in thenucleus [35]. In agreementwith these
observations, Par45 has a nuclear localization, although it lacks anyother
canonical nuclear-localization signal. To determine the subcellular
localization of T. cruzi Par45, we used different experimental approaches.
Indirect immunoﬂuorescence assays of epimastigotes indicated that
TcPar45 is highly concentrated within the nuclei but also revealed some
degree of cytoplasmic localization (Fig. 4A).No signalwasdetectedwhen
using the pre-immune serum (Fig. 4B) or the secondary antibody alone
(results not shown). In addition, examination of epimastigotes expres-
sing GFP fused to the C-terminal domain of TcPar45 revealed that the
ﬂuorescence was mainly restricted to the nuclei (data not shown).
Interestingly, using immunoﬂuorescencewith anti-TcPar45antibody,we
found that TbPar45 localization in the procyclic form of T. brucei closely
resembles that of the T. cruzi parvulin protein (Supplemental data S1). In
addition, to detect TbPar45 in procyclic formweused cell lines inwhich a
sequence encoding a V5 tag [32] had been introduced at the 5′ endof the
gene by homologous recombination. In these cells, the same nuclear
pattern was observed (Supplemental data S2). Taken together, these
results indicate that Par45 is mainly concentrated in the nuclei of both T.
cruzi and T. brucei parasites.
3.6. Silencing of TbPar45 expression causes a slow-growth phenotype
Gene-speciﬁc silencing by RNA interference (RNAi) is a valuable
tool for the analysis of gene function in the protozoan parasite T.brucei [40]. Given that null mutants are difﬁcult to obtain in T. cruzi
and that RNAi has failed to function in this organism [41], we decided
to explore the Par45 enzyme function in the procyclic form of the
RNAi-positive protozoa, T. brucei. To investigate whether TbPar45
depletion affected cell proliferation, an inducible RNAi cell line
expressing V5-tagged Par45 was generated using the procyclic Lister
427 29-13 strain. Following initiation of RNAi, the cells were re-
seeded every 24 h. The Northern blot analysis in Fig. 5 panel B shows
that in RNAi-induced cells the level of Par45 mRNA was reduced by
63% on day 4. This analysis also showed that the TbPin1 or TbPar14
mRNA abundancewas not affected in Par45RNAi cells (Fig. 5, panel B).
V5-tagged TbPar45 protein levels in induced cultures reached a
minimum of roughly 20–40% of that in non-induced cells after 2 days
(Fig. 5, panel A). We next evaluated the effect of RNAi on cell growth.
RNAi-induced cells grew normally for 3–4 days and then continued at
a lower rate, indicating that Par45 is required for maximum growth
rate (Fig. 5, panel C). Probably, the remaining levels are responsible
for the delayed onset of the growth phenotype. The effect on cell
division and kinetoplast segregation was monitored by staining of the
nuclear (N) and mitochondrial DNA (kinetoplast [K]) with DAPI and
visualization by ﬂuorescent microscopy (Fig. 5, panel D). The cells in
G1 and S phases seem to have one nucleus and one kinetoplast
(1N1K). Since K division precedes nuclear division, cells in the G2/M
Fig. 4. Localization of TcPar45. (Panel A) Epimastigote cells were ﬁxed and the endogenous Par45 protein was detected with anti-TcPar45 (1:200) and an Alexa 546-conjugated anti-
rabbit secondary antibody. Flagella were revealed with an anti-paraﬂagellar rod (anti-PFR, 1:2 dilution) mAb, followed by an Alexa 488-conjugated anti-mouse secondary antibody.
Phase contrast, DAPI staining and TcPar45 signals are indicated. The nucleus (N) and kinetoplast (k) were stained with DAPI. No signiﬁcant background staining was observed when
preimmune serum was used as a control (Panel B). The inserted box represents 2.5× zoom of the merge image. The images show one deconvolved Z-section using Autoquant X 2.1
software. Bar, 10 μm.
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undergoing cytokinesis have two nuclei and two kinetoplasts (2N2K).
In the control Par45 cell line (non-induced cells), 87% of the cells wereFig. 5. Effects of RNAi on TbPar45 in procyclic cells. TbPar45-RNAi cells were grown in the
counting. The cultures were re-seeded at 106 cells/ml with fresh tetracycline every 24 h. (P
time-course representative immunoblot of cell lysates using anti-V5 antibody (1:1000) is sho
of the original amount are shown. An antibody recognizing β-tubulin (1:5000) was used as t
level. A Northern blot was made with 30 µg of total RNA (3 days after tetracycline addition
TbPar14 and the resulting signals analyzed by PhosphorImager. The RNAr was used as loadin
or absence of tetracycline. (Panel D) Silencing of TbPar45 expression increases the number of
and 7th day time points. On the 7th day time point there is a marginal accumulation of xNx
point), normalized relative to total cell number, and expressed as mean±SE.found to have a normal-sized single nucleus and a single kinetoplast
(1N1K); the rest of the cells (13%) were mainly either 1N2K or 2N2K.
In induced cells, there was however, a marginal increase in thepresence or absence of tetracycline and samples were taken for immunoblotting and
anel A) Summary of quantitative immunoblotting of TbPar45 during RNAi induction. A
wn. The lysate from the non-induced sample was serially diluted and laneswith 25–65%
he load control. (Panel B) Northern blot showing speciﬁc effect of RNAi on Par45 mRNA
for RNAi cells), probed with 32P-labeled TbPar45 and then reprobed with TbPin1 and
g control. (Panel C) Representative growth curves of TbPar45 RNAi cells in the presence
aberrant cells. Quantiﬁcation of the cell cycle stages of the TbPar45 RNAi cells on the 3rd
K cells. Data were compiled from three independent experiments (nN1000 cells/time
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induced RNAi cell lines expressing endogenous (non-tagged) TbPar45
(data not shown).4. Discussion
In this study, we identiﬁed and characterized a newmember of the
parvulin-type PPIase subfamily, Par45, which is required for normal
cell proliferation in trypanosomes. Par45 represents the ﬁrst molecule
characterized that, in addition to a parvulin-like PPIase domain,
contains a conserved FHA protein–protein interaction domain. As
most characterized Pin1-like enzymes in eukaryotic organisms, Par45
exhibits an N-terminal extension beyond the conserved PPIase
domain extending for approximately 300 amino acids. Interestingly,
in most metazoans, the phospho-dependence of the substrate
recognition of Pin1-like PPIases requires a specialized WW domain
at this position [42,43]. However, in Par45, a WW domain is not
evident, but the presence of an FHA domain in its place could indicate
that it may serve an equivalent function. This domain organization,
including a PPIase and FHA, is found in some eukaryotic organisms
such as the green alga C. reinhardtii, the slime mold D. discoideum and
the trypanosomatids T. brucei and L. major, with potential orthologs
not present in the existing genome databases of prokaryotes and
higher eukaryotes such as plants and animals. The parvulin catalytic
core of TcPar45 displays striking similarity to the Pin1-type subfamily
of the parvulins. For example, TcPar45 shares 35.4% identity with the
PPIase domain of hPin1 and only 17.7% sequence identity with hPar14,
the latter of which does not exhibit the phosphorylation-dependent
substrate speciﬁcity (Fig. 1, panel A).
Attempts to express soluble TcPar45 in E. coli under a variety of
conditions were unsuccessful, precluding a complete biochemical
study. Because of this, the determination of the PPIase activity of T.
cruzi Par45 was performed using the recombinant catalytic PPIase
fragment of Par45. It is expected that the kinetics parameters using
the isolated catalytic domain of Par45 is present for the full-length
PPIase. Using the substrate Suc-Ala-Arg-Pro-Phe-NH-Np, the speciﬁc-
ity constant observed in the PPIase assay for TcPar45PPIase was about
three orders of magnitude (about 2000-fold) lower than the
respective value of kcat/KM for T. cruzi Par14 and about 40-fold less
active than human Par14 [13]. A comparison of the relative values of
the speciﬁcity constants for various substrates followed a pattern of T.
cruzi Par14with a preference for a substratewith the basic Arg residue
preceding prolyl bonds (Table 1). Interestingly, based on the residues
present in the Par45 sequence, and the presence of the basic triad
composed of Lys312, Arg317, and Arg318, which forms the recogni-
tion site for the phosphate group of Pin1 substrates [5,36,37], Par45 is
expected to exhibit a preference for acidic substrates, similar to that
observed for hPin1 and TcPin1. In this context, Par45 is a curious
example that demonstrates the impossibility to ascribe substrate
speciﬁcity based solely on sequence similarity. As it has been
previously shown, although pSer or pThr-binding activity of the
Pin1 WW domain is required for the protein function in vivo, the WW
domain has no inﬂuence on the substrate speciﬁcity [42]. In addition,
the low extent of the speciﬁcity constant of Par45PPIase of 97.1 /M/s
for the most favorable substrate may indicate that the reminiscent of
the natural binding partner of this parvulin has not yet been found
among the peptides assayed.
An excellent criterion for assigning parvulins to the Pin1-like sub-
group is the ability to replace Pin1/Ess1 functions in yeast. Indeed, it
has been shown that the PPIase domain of hPin1 is sufﬁcient for
rescuing the temperature-induced lethal phenotype in budding yeast
[8]. As we have previously veriﬁed, TcPin1 is able to complement the
otherwise lethal Ess1 loss in S. cerevisiae [24]. Failure of TcPar14 and
TcPar45 to rescue the lethal phenotype (Fig. 3) correlates with the
kinetics parameters observed in the in vitro PPIase assay (Table 1).The Par45 cellular localization is consistent with that of most FHA-
containingproteinsdescribed [35]. Twomethodsdesigned todetermine
the cellular localization, the expression of the protein in fusionwithGFP
and the indirect immunoﬂuorescence analysis, using the antibody
generated against the recombinant fragment Par45PPIase, indicated the
same cellular distribution in both T. cruzi epimastigote cells and T. brucei
procyclic form(Fig. 4 and Supplemental data S1 and S2). In epimastigote
cells, Par45 localized predominantly within nuclei. Remarkably, the
same subcellular localization was observed when endogenous TbPar45
was V5-tagged in the procyclic-form cell line 29-13 of T. brucei
(Supplemental data S2), suggesting that the localization of thismodiﬁed
version of the protein is not altered. Interestingly, hPin1 has been
localized almost exclusively in the cell nucleus and concentrated at
discrete structures [15,44].
While it was possible to obtain low levels of GFP tagged-Par45
expressed in epimastigote forms of T. cruzi, overexpression of the
molecule using the pTREX vector [45] could not be achieved (data not
shown), thus suggesting that high levels of Par45 are toxic for parasite
survival. Antibodies raised against TcPar45 showed that the PPIase
enzyme was present in all three stages of the parasite and that Par45
protein levels, as previously demonstrated for hPin1 [7], is constant
during the cell cycle (Fig. 2, panel B).
We here described the results of the downregulation of Par45 by
RNAi in the procyclic form of T. brucei. The high degree of conservation
between the Par45 proteins from T. cruzi and T. brucei (57.5% sequence
identity, Fig. 1, panel A), and the fact that both proteins display a similar
subcellular localization (Fig. 4 and supplemental data), allow us to infer
a similar function in both parasites. In this study, loss of TbPar45 in the
procyclic form produced a mild growth defect and a slight increase in
the number of abnormal xKxN cells (Fig. 5, panels A–D). Since
immunoblotting showed that there was still approximately 20–40% of
wild-type TbPar45 levels present in the RNAi cells, it could be that this is
sufﬁcient to maintain cell growth. Actually, in budding yeast, vanish-
ingly low levels of Ess1 PPIase activity are sufﬁcient to support cell
growth [46]. Taken together, these results suggest that Par45 might be
involved in the control of cell cycle progression, as shown for Ess1 in
yeast and for its counterpart Pin1 inHeLa cells [4]. However, the fact that
TcPar45 levels are constant in T. cruzi along the cell cycle (Fig. 2, panel B),
and given the relatively mild effects of RNAi in procyclic cells, a direct
role in the cell cycle control cannot be ascertained. Given the strength of
the phenotype in the procyclic form, future work will involve the
generation of a procyclic conditional knockout cell line. In addition, it is
worth pointing out that RNAi-mediated downregulation of TbPin1 and
TbPar14 did not abolish cell proliferation (data not shown).
One of the most intriguing questions is what the exact physiolog-
ical role of Par45 is, since this multi-domain parvulin has been
described in a small number of organisms. Interestingly, from the
studies on these multi-domain proteins, it can be argued that the
involvement of the PPIase domain in a given process is possibly
related to the functional properties of the accompanying FHA domain.
In hPin1, a commonWWprotein–protein interactionmodule is linked
to a C-terminal PPIase domain [4]. Early structure-to-function
analyses have revealed that the unique substrate speciﬁcity of Pin1
towards speciﬁc pSer/Thr-Pro motifs results from interactions
provided by both of these domains, which form a 'double-check'
mechanism ([4] and references therein). In Par45, both domains seem
to function independently. Taking into account that in Par45 the
protein–protein interaction FHA domain is coupled to a PPIase
domain, it seems plausible that the two domains could act on
different motifs on the same target protein. Intriguingly, whereas FHA
is a pThr-binding module, the catalytic PPIase domain of Par45
displayed substrate speciﬁcity towards Arg-Pro motifs to regulate
protein function by controlling their conformations. Recent works
have shown that the FHA domains of NIPP1 and other FHA-containing
proteins preferentially bind pThr-Pro-containing peptide stretches
[47–49]. This striking characteristic places the FHA domain in a
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theWWdomain found in Pin1-type PPIases. It would be interesting to
determine whether the FHA domain of Par45 uses a common
mechanism of Pro recognition at this position.
In conclusion, we identiﬁed and biochemically characterized a
novel parvulin-type PPIase from the evolutionary divergent T. cruzi.
Our results reveal an unexpected substrate speciﬁcity of the Par45
enzyme. The presence of PPIases in trypanosomes, together with the
presence of the atypical TcPar45, underscores the importance of
prolyl cis/trans isomerization in various biological processes during
the life of trypanosomes. Furthermore, given that there are
orthologs in L. major and T. brucei, the role of Par45 requires further
investigation.
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